Ignite Creation Date:
2025-12-24 @ 11:52 AM
Ignite Modification Date:
2025-12-24 @ 11:52 AM
Study NCT ID:
NCT01894061
Status:
COMPLETED
Last Update Posted:
2025-02-17
First Post:
2013-07-03
Is Possible Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
Sponsor:
Organization: